Emoclot 500 IU/10ml

    Product information

    Emoclot is a concentrated solution of the anti-haemorrhagic factor VIII containing the essential protein for blood coagulation. It is a human plasma derived product for intravenous injection, lyophilized after a double viral inactivation.

    Emoclot is used in:

    • haemorrhages treatment and prophylaxis of patients with congenital deficit of factor VIII (haemophilia A); treatment of acquired deficit of factor VIII;
    • treatment of haemophilic patients with developed antibody against factor VIII (inhibitors).
    + Read more

    Detailed information

    Registration number:
    EPD-IES-0000888:002 (S-P-00888)
    Status:
    Valid
    PCR:
    2016:07
    En15804 Compliant:
    No
    Registration date:
    January 23, 2018
    Version date:
    June 22, 2023
    Valid until:
    July 18, 2028
    Geographical scopes:
    Global
    LCA practitioner:
    elena.neri@indaco2.it

    EPD Owner

    Logotype
    Company Name:
    Kedrion SpA
    Country:
    Italy
    Contact:
    m.bonaldi@kedrion.com
    Website:
    http://www.kedrion.com/

    EPD documents

    EPD document S-P-00888 en.pdf

    Included products in this EPD

    EMOCLOT 500 IU/10mL

    EPD QR code

    Use this QR code to link directly to this page